Omega Therapeutics Ownership | Who Owns Omega Therapeutics?


OverviewForecastRevenueFinancialsChart

Omega Therapeutics Ownership Summary


Omega Therapeutics is owned by 3.27% institutional investors, 1.67% insiders, and 95.06% retail investors. Flagship pioneering is the largest institutional shareholder, holding 52.99% of OMGA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.09% of its assets in Omega Therapeutics shares.

OMGA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOmega Therapeutics3.27%1.67%95.06%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering29.23M52.99%$21.79M
Fmr5.92M10.74%$4.42M
Harbourvest partners3.51M6.37%$2.62M
State of wisconsin investment board1.86M3.37%$1.38M
Siren1.32M2.40%$986.82K
Vanguard group1.10M1.99%$818.44K
Blue owl capital lp1.06M1.91%$787.27K
683 capital management600.00K1.09%$447.36K
Millennium management520.90K0.94%$388.38K
72 investment352.94K0.64%$263.15K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering29.23M6.52%$21.79M
Harbourvest partners3.51M1.29%$2.62M
72 investment352.94K0.54%$263.15K
Blue owl capital lp1.06M0.18%$787.27K
Long corridor asset management85.00K0.05%$63.38K
Siren1.32M0.04%$986.82K
683 capital management600.00K0.03%$447.36K
Murphy pohlad asset management16.50K0.01%$12.30K
State of wisconsin investment board1.86M0.00%$1.38M
Rbf capital63.86K0.00%$47.61K

Top Buyers

HolderShares% AssetsChange
Ubs group163.90K-160.91K
Woodline partners lp122.19K0.00%122.19K
Raymond james financial30.09K-30.09K
Colony group14.00K-14.00K
Two sigma securities12.05K0.00%12.05K

Top Sellers

HolderShares% AssetsChange
Renaissance17.82K--456.78K
Platinum investment management---346.35K
Fmr5.92M0.00%-137.26K
State of michigan retirement system224.12K0.00%-90.00K
Two sigma investments, lp21.74K--59.35K

New Positions

HolderShares% AssetsChangeValue
Woodline partners lp122.19K0.00%122.19K$91.11K
Raymond james financial30.09K-30.09K$22.44K
Two sigma securities12.05K0.00%12.05K$8.99K
Bnp paribas arbitrage, snc235.00-235.00$175.00

Sold Out

HolderChange
Srs capital advisors-54.00
Advisor group-200.00
Harbour investments-275.00
Simplex trading-1.51K
Squarepoint ops-18.16K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202413-76.36%1,801,047-96.27%30.04%4-73.33%3-76.92%
Sep 30, 202455-20.29%48,291,711-4.44%871.04%15-50.00%13-38.10%
Jun 30, 202469-5.48%50,536,106-1.17%911.07%30-18.92%2150.00%
Mar 31, 20247312.31%51,136,5801.80%921.12%3723.33%14-30.00%
Dec 31, 2023656.56%50,233,395-1.29%911.07%3011.11%2042.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.82M5.09%-
Fidelity Growth Company Fund1.96M3.55%-4.04K
Vanguard Total Stock Mkt Idx Inv779.10K1.41%-
Fidelity Growth Company K6741.11K1.34%-7.38K
Fidelity Series Growth Company389.58K0.70%-30.70K
Vanguard Institutional Extnd Mkt Idx Tr309.87K0.56%-
Galileo - Biotech Innovation Fund S USD175.00K0.32%-
Fidelity Extended Market Index119.92K0.22%-1.82K
Bridgeway Ultra-Small Company Market64.00K0.12%-55.00K
iShares Micro-Cap ETF59.57K0.11%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 02, 2023Young Richard A-Sell$40.00K
May 01, 2023Young Richard A-Sell$40.00K
Apr 06, 2023Young Richard A-Sell$40.00K
Mar 17, 2023Young Richard A-Sell$80.00K
Feb 27, 2023Flagship Pioneering Inc.-Buy$11.53M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q3--
2023 Q2-3

OMGA Ownership FAQ


Who Owns Omega Therapeutics?

Omega Therapeutics shareholders are primarily institutional investors at 3.27%, followed by 1.67% insiders and 95.06% retail investors. The average institutional ownership in Omega Therapeutics's industry, Biotech Stocks , is 68.48%, which Omega Therapeutics falls below.

Who owns the most shares of Omega Therapeutics?

Omega Therapeutics’s largest shareholders are Flagship pioneering (29.23M shares, 52.99%), Fmr (5.92M shares, 10.74%), and Harbourvest partners (3.51M shares, 6.37%). Together, they hold 70.10% of Omega Therapeutics’s total shares outstanding.

Does Blackrock own Omega Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Omega Therapeutics.

Who is Omega Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Omega Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.52% of its assets in 29.23M Omega Therapeutics shares, valued at 21.79M$.

Who is the top mutual fund holder of Omega Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Omega Therapeutics shares, with 5.09% of its total shares outstanding invested in 2.82M Omega Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools